The Experts below are selected from a list of 144 Experts worldwide ranked by ideXlab platform
Dan Wang - One of the best experts on this subject based on the ideXlab platform.
-
Risk factor for Steatorrhea in pediatric chronic pancreatitis patients.
BMC Gastroenterology, 2018Co-Authors: Lu Hao, Di Zhang, Teng Wang, Xiang-peng Zeng, Lei Xin, Jun Pan, Dan WangAbstract:Background Pediatric patients always suffer from chronic pancreatitis (CP), especially those with Steatorrhea. This study aimed to identify the incidence of and risk factors for Steatorrhea in pediatric CP. To our best knowledge, there is no pediatric study to document the natural history of Steatorrhea in CP.
-
Risk factor for Steatorrhea in pediatric chronic pancreatitis patients
BMC, 2018Co-Authors: Lu Hao, Di Zhang, Teng Wang, Xiang-peng Zeng, Lei Xin, Jun Pan, Dan WangAbstract:Abstract Background Pediatric patients always suffer from chronic pancreatitis (CP), especially those with Steatorrhea. This study aimed to identify the incidence of and risk factors for Steatorrhea in pediatric CP. To our best knowledge, there is no pediatric study to document the natural history of Steatorrhea in CP. Methods CP patients admitted to our center from January 2000 to December 2013 were enrolled. Patients were assigned to the pediatric (
-
The cumulative rates after the diagnosis of pancreatic stone.
2018Co-Authors: Lu Hao, Dan Wang, Teng Wang, Jun Pan, Li-sheng Wang, Yu Liu, Hong-lei Guo, Lei XinAbstract:(A) The cumulative rates of diabetes mellitus; (B) The cumulative rates of Steatorrhea. ACP = alcoholic chronic pancreatitis, DM = diabetes mellitus, ICP = idiopathic chronic pancreatitis.
-
Steatorrhea in patients with chronic pancreatitis and the risk factors
2016Co-Authors: Jin-huan Lin, Zhuan Liao, Zhao-hong Zheng, Dan Wang, Di ZhangAbstract:Objective To investigate the occurrence and risk factors of Steatorrhea in chronic pancreatitis (CP) patients. Methods Data of CP patients admitted to Department of Gastroenterology in Changhai Hospital from January 2000 to December 2008 were retrospectively analyzed.The cumulative rate of Steatorrhea was calculated by using the Kaplan-Meier method. Univariate analysis and multivariate Cox proportional hazards regression model was performed to detect risk factors for Steatorrhea. Results A total of 591 CP patients were included and 85.62% of them were followed up with an average duration of (10.6±6.3) years. There were 152(25.72%) patients who had Steatorrhea and the ratio of men to women was 3.61∶1. The main cause for Steatorrhea was ICP and there were 120 ICP patients who had Steatorrhea. The cumulative rates of Steatorrhea at 1, 5 and 10 years after CP diagnosis were 20%, 26% and 29%, respectively, and no significant differences were detected on the incidence in male and female patients (P=0.143). Nine variables identified from univariate analyses were involved in Cox proportional hazards regression mode1 were age of CP onset, age of CP diagnosis, gender, drinking, smoking, genetic factors, biliary stenosis, pancreatic pseudocyst and abdominal pain. The results demonstrated that age of CP onset (RR=1.055, P=0.035), biliary stenosis (RR=1.943, P=0.041) and abdominal pain (RR=0.419, P=0.006) were the independent risk factors for Steatorrhea in CP patients. Conclusions More than 25% of CP patients developed Steatorrhea and old age of onset, biliary stenosis and abdominal pain were three independent risk factors for Steatorrhea. Key words: Pancreatitis, chronic; Steatorrhea; Risk factors
-
risk factors for Steatorrhea in chronic pancreatitis a cohort of 2 153 patients
Scientific Reports, 2016Co-Authors: Jun Pan, Jin-huan Lin, Zhuan Liao, Zhao-hong Zheng, Dan Wang, Wenbin Zou, Hui Chen, Shoubin NingAbstract:This study aimed to investigate the occurrence of and determine the risk factors for Steatorrhea in chronic pancreatitis (CP). It was based on analysis of both retrospectively and prospectively acquired database for CP patients admitted to our center from January 2000 to December 2013. Demographic data, course of disease, medical history and follow-up evaluations of patients were documented in detail. Cumulative rate of Steatorrhea was calculated by using the Kaplan–Meier method. For risk factor analysis, multivariate analysis by Cox proportional hazards regression model was performed. A total of 2,153 CP patients were included with a mean follow-up duration of 9.3 years. Approximately 14% (291/2,153) of CP patients presented with Steatorrhea at diagnosis of CP. Cumulative rates of Steatorrhea at 1, 5, 10 and 20 years after diagnosis of CP were 4.27% (95% CI: 3.42%–5.34%), 12.53% (95% CI: 10.74%–14.59%), 20.44% (95% CI: 17.37%–23.98%) and 30.82% (95% CI: 20.20%–45.21%), respectively. Male gender (HR = 1.771, p = 0.004), diabetes (HR = 1.923, p < 0.001), alcohol abuse (HR = 1.503, p = 0.025) and pancreaticoduodenectomy (HR = 2.901, p < 0.001) were independent risk factors for Steatorrhea while CP in adolescents (HR = 0.433, p = 0.009) was a protective factor. In conclusion, male gender, adult, diabetes, alcohol abuse and pancreaticoduodenectomy lead to increased risk of Steatorrhea in CP patients.
Jin Kyung Kang - One of the best experts on this subject based on the ideXlab platform.
-
are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic Steatorrhea
The American Journal of Gastroenterology, 2001Co-Authors: Jun Pyo Chung, Hyojin Park, Jae Bock Chung, Jin Kyung KangAbstract:Are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic Steatorrhea?
Jun Pan - One of the best experts on this subject based on the ideXlab platform.
-
Risk factor for Steatorrhea in pediatric chronic pancreatitis patients.
BMC Gastroenterology, 2018Co-Authors: Lu Hao, Di Zhang, Teng Wang, Xiang-peng Zeng, Lei Xin, Jun Pan, Dan WangAbstract:Background Pediatric patients always suffer from chronic pancreatitis (CP), especially those with Steatorrhea. This study aimed to identify the incidence of and risk factors for Steatorrhea in pediatric CP. To our best knowledge, there is no pediatric study to document the natural history of Steatorrhea in CP.
-
Risk factor for Steatorrhea in pediatric chronic pancreatitis patients
BMC, 2018Co-Authors: Lu Hao, Di Zhang, Teng Wang, Xiang-peng Zeng, Lei Xin, Jun Pan, Dan WangAbstract:Abstract Background Pediatric patients always suffer from chronic pancreatitis (CP), especially those with Steatorrhea. This study aimed to identify the incidence of and risk factors for Steatorrhea in pediatric CP. To our best knowledge, there is no pediatric study to document the natural history of Steatorrhea in CP. Methods CP patients admitted to our center from January 2000 to December 2013 were enrolled. Patients were assigned to the pediatric (
-
The cumulative rates after the diagnosis of pancreatic stone.
2018Co-Authors: Lu Hao, Dan Wang, Teng Wang, Jun Pan, Li-sheng Wang, Yu Liu, Hong-lei Guo, Lei XinAbstract:(A) The cumulative rates of diabetes mellitus; (B) The cumulative rates of Steatorrhea. ACP = alcoholic chronic pancreatitis, DM = diabetes mellitus, ICP = idiopathic chronic pancreatitis.
-
risk factors for Steatorrhea in chronic pancreatitis a cohort of 2 153 patients
Scientific Reports, 2016Co-Authors: Jun Pan, Jin-huan Lin, Zhuan Liao, Zhao-hong Zheng, Dan Wang, Wenbin Zou, Hui Chen, Shoubin NingAbstract:This study aimed to investigate the occurrence of and determine the risk factors for Steatorrhea in chronic pancreatitis (CP). It was based on analysis of both retrospectively and prospectively acquired database for CP patients admitted to our center from January 2000 to December 2013. Demographic data, course of disease, medical history and follow-up evaluations of patients were documented in detail. Cumulative rate of Steatorrhea was calculated by using the Kaplan–Meier method. For risk factor analysis, multivariate analysis by Cox proportional hazards regression model was performed. A total of 2,153 CP patients were included with a mean follow-up duration of 9.3 years. Approximately 14% (291/2,153) of CP patients presented with Steatorrhea at diagnosis of CP. Cumulative rates of Steatorrhea at 1, 5, 10 and 20 years after diagnosis of CP were 4.27% (95% CI: 3.42%–5.34%), 12.53% (95% CI: 10.74%–14.59%), 20.44% (95% CI: 17.37%–23.98%) and 30.82% (95% CI: 20.20%–45.21%), respectively. Male gender (HR = 1.771, p = 0.004), diabetes (HR = 1.923, p < 0.001), alcohol abuse (HR = 1.503, p = 0.025) and pancreaticoduodenectomy (HR = 2.901, p < 0.001) were independent risk factors for Steatorrhea while CP in adolescents (HR = 0.433, p = 0.009) was a protective factor. In conclusion, male gender, adult, diabetes, alcohol abuse and pancreaticoduodenectomy lead to increased risk of Steatorrhea in CP patients.
-
Risk Factors for Steatorrhea in Chronic Pancreatitis: A Cohort of 2,153 Patients
Scientific Reports, 2016Co-Authors: Jun Pan, Zhuan Liao, Zhao-hong Zheng, Wenbin Zou, Hui Chen, Dan WangAbstract:This study aimed to investigate the occurrence of and determine the risk factors for Steatorrhea in chronic pancreatitis (CP). It was based on analysis of both retrospectively and prospectively acquired database for CP patients admitted to our center from January 2000 to December 2013. Demographic data, course of disease, medical history and follow-up evaluations of patients were documented in detail. Cumulative rate of Steatorrhea was calculated by using the Kaplan–Meier method. For risk factor analysis, multivariate analysis by Cox proportional hazards regression model was performed. A total of 2,153 CP patients were included with a mean follow-up duration of 9.3 years. Approximately 14% (291/2,153) of CP patients presented with Steatorrhea at diagnosis of CP. Cumulative rates of Steatorrhea at 1, 5, 10 and 20 years after diagnosis of CP were 4.27% (95% CI: 3.42%–5.34%), 12.53% (95% CI: 10.74%–14.59%), 20.44% (95% CI: 17.37%–23.98%) and 30.82% (95% CI: 20.20%–45.21%), respectively. Male gender (HR = 1.771, p = 0.004), diabetes (HR = 1.923, p
David M Orenstein - One of the best experts on this subject based on the ideXlab platform.
-
a comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of Steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency
The American Journal of Gastroenterology, 2000Co-Authors: Robert C Stern, Jay D Eisenberg, Guillermo A Dopico, Richard C Ahrens, Jeffrey S Wagener, Michael G. Rock, David M OrensteinAbstract:A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of Steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency
Jun Pyo Chung - One of the best experts on this subject based on the ideXlab platform.
-
are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic Steatorrhea
The American Journal of Gastroenterology, 2001Co-Authors: Jun Pyo Chung, Hyojin Park, Jae Bock Chung, Jin Kyung KangAbstract:Are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic Steatorrhea?
